Jane Pritchett Henderson - 12 Aug 2025 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
Director
Signature
/s/ Jonathan Young, Attorney-in-Fact
Issuer symbol
AKRO
Transactions as of
12 Aug 2025
Net transactions value
-$121,344
Form type
4
Filing time
12 Aug 2025, 20:32:47 UTC
Previous filing
20 Jun 2025
Next filing
19 Aug 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Henderson Jane Director 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO /s/ Jonathan Young, Attorney-in-Fact 12 Aug 2025 0001422304

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $21,027 +3,000 +32% $7.01 12,398 12 Aug 2025 Direct
transaction AKRO Common Stock Sale $142,371 -3,000 -24% $47.46 9,398 12 Aug 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -3,000 -20% $0.000000 11,797 12 Aug 2025 Common Stock 3,000 $7.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are vested and currently exercisable.